Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results
Date:11/9/2011

83$ 150,669  Accounts receivable

2,0153,499  Other current assets

2,4862,638  Land, property & equipment, net

85,24591,533  Acquired technology & other non-current assets

17,37018,023Total assets

$ 184,999$ 266,362Liabilities and Stockholders' Equity  Accounts payable and accrued liabilities

$   9,608$   10,680  Total deferred revenues

45,20148,077  Total derivative liabilities

1,2772,271  Total note payable to Siegfried

3,68610,361  Total note payable to Deerfield (2)

13,76937,777  Total lease financing obligations & other long-term liabilities

76,31977,181  Total stockholders' equity

35,13980,015Total liabilities & stockholders' equity

$ 184,999$ 266,362(1)

The Condensed Consolidated Balance Sheet Data has been derived from the audited financial statements as of that date.(2)

The outstanding principal balance of the note payable to Deerfield was $22.3 million at September 30, 2011 and $60.0 million at December 31, 2010.Contacts:

Arena Pharmaceuticals, Inc.

Robert E. Hoffman

Vice President, Finance and Chief Financial Officer858.453.7200, ext. 222

Investor Inquiries: Russo Partners

Cindy McGee, Vice President

cindy.mcgee@russopartnersllc.com

619.308.6538Media Inquiries: Russo Partners

David Schull, President

david.schull@russopartnersllc.com

858.717.2310
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
2. Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
3. Arena Pharmaceuticals Announces Second Quarter 2011 Financial Results
4. Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
5. Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
6. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
7. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
8. Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals Lorcaserin Achieved Statistically Significant Weight Loss
9. Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
10. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
11. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... TUCSON, Ariz. , Aug. 20, 2014 /PRNewswire/ ... of the  Roche  Group, today announced that its ... been CE marked in the European Union for ... specimens. The system, consisting of VENTANA Virtuoso software ... the VENTANA iScan HT slide scanner, provides automated ...
(Date:8/20/2014)... Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces that ... has received Chinese FDA (CFDA) approval and has ... into the China domestic ... distribution agreement with Sinochem Jiangsu Pharmaceutical Co., Ltd., ... FDA approved and China CFDA certified oral solid ...
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that a ... catalogue: The Market for Medical Devices ... The European, Middle Eastern and African markets represent ... part of its coverage, this study: The Market ... EMEA medical device markets and estimates markets for ...
Breaking Medicine Technology:Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5
...   " The   Obama administration will ... urban counterparts in adopting technology to improve healthcare quality." ... online health records . " What ... national healthcare IT programmes and initiatives are currently taking place across ...
... WHITE PLAINS, N.Y., Aug. 19, 2011 Today the ... to treat two types of rare blood cancers – ... (Logo: http://photos.prnewswire.com/prnh/20110215/NY48642LOGO) The drug is approved ... cell transplant or two chemotherapy treatments and for ALCL ...
Cached Medicine Technology:Innovations in E-Health & Informatics Europe: The Need for a European EHealth Strategy 2The Leukemia & Lymphoma Society Available to Comment on FDA Approval of Seattle Genetics' Adcetris, First New Treatment for Hodgkin Lymphoma Since 1977 2
(Date:8/20/2014)... Top10BestSEOHosting.com is a website dedicated to providing ... is headed by a team of experts and ... information and factual studies about the newest hosting ... , Recently, Top10BestSEOHosting.com has compared many Linux ... and Bluehost are the most recommended suppliers for ...
(Date:8/20/2014)... Today, Zane Benefits, the #1 ... a new eBook, Affordable Care Act 101. , ... feel uncertain about how the ACA impacts their ... line. , The new eBook outlines key ACA ... their upcoming health insurance decisions. , Read the ...
(Date:8/20/2014)... -- A group representing U.S. obstetricians is calling for ... According to the American College of Obstetricians and Gynecologists ... the safety and effectiveness of flu vaccination during pregnancy. ... be particularly dangerous to pregnant women, as it can ... Riley, chair of the college,s Immunization Expert Work Group, ...
(Date:8/20/2014)... than 42 percent of women underwent breast reconstruction ... associated with foregoing reconstruction included being black, having ... Author: Monica Morrow, M.D., of the Memorial Sloan ... Background: The Women,s Health and Cancer Rights Act ... following a mastectomy. Still, most women who undergo ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Hundreds of ... behalf of women who were allegedly injured due to ... in New Jersey’s Bergen County Superior Court, Bernstein Liebhard ... on August 15, 2014, the Court has established procedures ... Mirena lawsuits that are part of the proceeding’s initial ...
Breaking Medicine News(10 mins):Health News:New Reviews For Linux Web Hosting Suppliers Announced By Top10BestSEOHosting.com 2Health News:All Pregnant Women Need Flu Shot: Ob/Gyn Group 2Health News:Patient perspectives on breast reconstruction following mastectomy 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 4
... , THURSDAY, Nov. 24 (HealthDay News) -- Black Friday, the ... the quest as it is about getting good deals, according ... the Black Friday adventure phenomenon, the more fun you,re likely ... professor at Wake Forest University, said in a university news ...
... THURSDAY, Nov. 24 (HealthDay News) -- The holiday season can ... there are a number of things they can do to ... because many traditional holiday foods contain such allergens as wheat, ... news release from the American College of Allergy, Asthma and ...
... or processed meat is positively associated with aggressive prostate cancer, ... journal PLoS ONE . The research ... Francisco, also found that the correlation was primarily driven by ... done. They suggest that this result, which was ...
... HealthDay Reporter , WEDNESDAY, Nov. 23 (HealthDay ... not an asthma diagnosis are often prescribed inhaled steroid ... those medications on an as-needed basis instead of every ... wheezing in young children, and the treatment for some ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, Nov. ... that the drug company Merck will pay $950 million to ... which was pulled from the market in 2004 after studies ... stroke. Merck will pay $321.6 million in criminal ...
... the numbers indicate that improvements are possible," says Hyland at ... in Boston, USA, 234 million major surgical procedures are conducted ... human beings undergoes a major surgical procedure each year. ... According to the WHO, serious complications occur in three to ...
Cached Medicine News:Health News:Allergy Sufferers Should Prepare for Holiday Triggers 2Health News:Intermittent Steroid Use Called OK for Wheezing Preschoolers 2Health News:Intermittent Steroid Use Called OK for Wheezing Preschoolers 3Health News:Merck to Pay $950M to Settle Probe of Vioxx Marketing 2Health News:Merck to Pay $950M to Settle Probe of Vioxx Marketing 3Health News:Creating safer surgery to save more lives 2Health News:Creating safer surgery to save more lives 3
... An APTT-based kit for the screening of ... specificity of the test for the factor ... sample plasma with an excess of V-DEF ... possible to discriminate between heterozygous and homozygous ...
Inquire...
Inquire...
... remarkable anti-reflux valve is enclosed ... which prevents the valve from ... in sitting or reclining positions. ... and interference free ensuring uninterrupted ...
Medicine Products: